IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT001065 (Q83591113)
Jump to navigation
Jump to search
scientific article published on 06 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT001065 |
scientific article published on 06 March 2012 |
Statements
IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522) (English)
Morten A Karsdal
Georg Schett
Olivier Harari
Inger Byrjalsen
Andy Kenwright
Anne C Bay-Jensen